SMMT
SMMT clinical trials: Summit Therapeutics Inc.
Every trial on ClinicalTrials.gov where Summit Therapeutics Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 42
- Trials linked
- 13
- As lead sponsor
- 29
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
SMMT on the catalyst calendar · SMMT registry changes
- Primary completion Apr 2028Sponsor estimatePhase 3NCT06767514Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1Summit Therapeutics · Non-Small Cell Lung CancerRecruitingSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 31, 2028Sponsor estimatePhase 3NCT07228832Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal CancerSummit Therapeutics · Metastatic Colorectal Cancer (CRC)RecruitingSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 12, 2029Sponsor estimatePhase 2NCT07877194A Clinical Study of Ivonescimab in Combination With Cadonilimab or Ipilimumab for Advanced Renal CancerSummit Therapeutics · Renal Cell Carcinoma, Clear CellNot yet recruitingSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 17, 2021ActualPhase 3NCT03595553Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile InfectionSummit Therapeutics · Clostridioides Difficile InfectionCompletedSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2028Sponsor estimatePhase 3NCT05899608Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC PatientsSummit Therapeutics · Non-Small Cell Lung CancerActive, not recruitingSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 31, 2030Sponsor estimatePhase 2/Phase 3NCT07815665A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic...Summit Therapeutics · Metastatic Urothelial CarcinomaRecruitingSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 12, 2025ActualPhase 3NCT06396065Phase III Study of AK112 for NSCLC PatientsSummit Therapeutics · Non-Squamous Non-small Cell Lung CancerActive, not recruitingSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 17, 2021ActualPhase 3NCT04802837Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent SubjectsSummit Therapeutics · Clostridioides Difficile InfectionTerminatedSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 11, 2018ActualPhase 2NCT02858362Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD)Summit Therapeutics · Duchenne Muscular DystrophyTerminatedSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2016ActualPhase 2NCT02784002A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI)Summit Therapeutics · Clostridium Difficile InfectionCompletedSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2015ActualPhase 2NCT02092935A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)Summit Therapeutics · Clostridium Difficile InfectionCompletedSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2015ActualPhase 1NCT02383511Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced DietSummit Therapeutics · Muscular Dystrophy, DuchenneCompletedSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2014ActualPhase 1NCT02056808A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD)Summit Therapeutics · Duchenne Muscular DystrophyCompletedSMMTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 1, 2028Sponsor estimatePhase 2NCT06959550Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal CancerM.D. Anderson Cancer Center · Metastatic Colorectal CancerRecruitingSMMTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 1, 2028Sponsor estimatePhase 2NCT06567314Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell CarcinomaM.D. Anderson Cancer Center · Cutaneous Squamous Cell CarcinomaRecruitingSMMTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2029Sponsor estimatePhase 1NCT05536141A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid TumorsArcus Biosciences, Inc. · Clear Cell Renal Cell CarcinomaRecruitingRCUSLeadSMMTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2029Sponsor estimatePhase 1/Phase 2NCT07397338Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid TumorsRevolution Medicines, Inc. · Advanced Solid TumorsRecruitingRVMDLeadSMMTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2029Sponsor estimatePhase 2NCT07917481A Clinical Study Evaluating the Safety and Efficacy of Ivonescimab as Second-line Treatment in Patients With Advanced Hepatocellular...MedSIR · Hepatocellular Carcinoma (HCC)Not yet recruitingSMMTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2029Sponsor estimatePhase 2NCT07516925A Study of Ivonescimab in People With LeiomyosarcomaMemorial Sloan Kettering Cancer Center · LeiomyosarcomaRecruitingSMMTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 1, 2027Sponsor estimatePhase 2NCT06805617A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland CancersDana-Farber Cancer Institute · Salivary Gland CancerRecruitingSMMTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 17, 2027Sponsor estimatePhase 2NCT06980077Ivonescimab for the Treatment of Thymic CancerJonsson Comprehensive Cancer Center · Thymus CarcinomaRecruitingSMMTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2027Sponsor estimatePhase 2NCT06925724A Study of Ivonescimab in People With Endometrial and Cervical CancersMemorial Sloan Kettering Cancer Center · Endometrial CancerRecruitingSMMTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 1, 2028Sponsor estimatePhase 2NCT07743138STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma...M.D. Anderson Cancer Center · Adrenocortical CarcinomaNot yet recruitingSMMTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2029Sponsor estimatePhase 1NCT07619339A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung CancerMemorial Sloan Kettering Cancer Center · Non-Small Cell Lung CancerRecruitingSMMTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2026Sponsor estimatePhase 2NCT07070466Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEAMassachusetts General Hospital · Stomach Cancer Stage IVRecruitingSMMTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 17 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner